Rumors have circulated that French biotechnology company Abivax (ABVX) has been attracting interest from Eli Lilly (LLY), according to a report in the French-language La Tribune. Abivax shares, which jumped on Monday, are up $4.62, or 3%, to $142.97 in pre-market trading in New York.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABVX: